Vivus: into single digits Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vivus: into single digits

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BDR who wrote (959)	9/6/1998 10:09:00 PM
From: VLAD	Read Replies (2) of 1016

Very crude and crass remark coming from a supposed doctor. MUSE was extremely popular last year when the alternatives were to stick an needle in it or have a plastic bubble sutured into it. Not a bad alternative considering the options. Looks to me like the magic blue pill is rapidly loosing its magic. No MUSE certainly is not perfect but if marketed properly (50 sales people calling on 8,000 urologists in 1997 IMO is not effective marketing) it can make a small biotech company such as Vivus very profitable. It should be interesting to see how domestic sales do if Astra partners domestically. We can then see if it is the product or lack of marketing. Time will tell.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next